🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ACAD

ACADIA Pharmaceuticals Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 05, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Health Care🏭 Pharmaceuticals
AVG HISTORICAL GAP-1.24%
MAX GAP RECORD-18.30%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.9%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL